The final piece of my PhD work is now published in Science Translational Medicine! We present a new framework to jointly infer epidemiological and antigenic parameters from multi-pathogen population serological studiesπ¦
www.science.org/stoken/autho...
18.12.2025 10:04
π 32
π 13
π¬ 1
π 1
Whose line is it anyway? Defining sero-positivity cut-offs for infectious disease surveillance
β
Just Accepted
#IDSky
π https://bit.ly/4qoQdUq
24.10.2025 15:49
π 2
π 3
π¬ 1
π 1
From the now published pan-disease blood atlas, we used the proteomic data together with clinical and single-cell data to describe immune cross-talk linked with disease severity in malaria @cp-immunity.bsky.social
Check it out!
www.sciencedirect.com/science/arti...
#Immunology #malaria @ki.se
10.10.2025 14:37
π 9
π 3
π¬ 1
π 0
Dengue disease severity in humans is augmented by waning Japanese encephalitis virus immunity
Waning immunity to Japanese encephalitis virus was associated with increased severity of dengue disease in a cohort of patients from Nepal.
A new analysis of a cohort in Nepal links the waning of vaccine immunity against Japanese encephalitis virus to elevated chymase levels and a higher risk of severe #dengue infection.
Read more in #ScienceTranslationalMedicine: https://scim.ag/45ORL27
04.09.2025 15:00
π 19
π 7
π¬ 0
π 1
Systems analysis of clinical malaria reveals proteomic perturbation and innate-adaptive crosstalk linked to disease severity
While the immune response to Plasmodium falciparum malaria has been studied extensively,
the circulating proteome and its cellular origins remain poorly characterized. Lautenbach
et al. address this b...
Proud coβauthor on @cp-immunity.bsky.social study by Julius Lautenbach, @chrissundling.bsky.social & Team FΓ€rnert w/ HPA & @scilifelab.se. We integrate plasma proteome dynamics (1500 proteins) + scRNA-seq in acute malaria, identifying severity markers & exploring immune-cell communication.
16.07.2025 10:34
π 5
π 3
π¬ 0
π 0
Great update on alphaviruses
19.05.2025 06:12
π 3
π 0
π¬ 0
π 0
Research in context panel from Lancet paper "Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study". Copyright: 2025 Elsevier Ltd. All rights are reserved.
Potential first new antibiotic for gonorrhoea since the 1990s is effective and safe, finds trial.
Explore the research β‘οΈ tinyurl.com/5bu2nbyt #ESCMID #ESCMIDGlobal
15.04.2025 15:05
π 99
π 38
π¬ 4
π 7
Beautiful study of primaquine treatment to prevent vivax malaria relapses from Jean Popovici's team from Pasteur Cambodia.
The study is special because patients were moved to a non-endemic part of Cambodia, excluding reinfection from msoquitoes.
authors.elsevier.com/sd/article/S...
18.03.2025 09:16
π 7
π 2
π¬ 0
π 0